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Abstract
From time immemorial, vector-borne diseases have severely reduced the ﬁghting capacity of armies and caused suspension or cancellation
of military operations. Since World War I, infectious diseases have no longer been the main causes of morbidity and mortality among sol-
diers. However, most recent conﬂicts involving Western armies have occurred overseas, increasing the risk of vector-borne disease for
the soldiers and for the displaced populations. The threat of vector-borne disease has changed with the progress in hygiene and disease
control within the military: some diseases have lost their military signiﬁcance (e.g. plague, yellow fever, and epidemic typhus); others remain
of concern (e.g. malaria and dengue fever); and new potential threats have appeared (e.g. West Nile encephalitis and chikungunya fever).
For this reason, vector control and personal protection strategies are always major requirements in ensuring the operational readiness of
armed forces. Scientiﬁc progress has allowed a reduction in the impact of arthropod-borne diseases on military forces, but the threat is
always present, and a failure in the context of vector control or in the application of personal protection measures could allow these
diseases to have the same devastating impact on human health and military readiness as they did in the past.
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Introduction
Through the ages, wartime epidemics have severely reduced
the ﬁghting strength of armies, caused the suspension and
cancellation of military operations, and wrought havoc on
the civilian populations of belligerent and non-belligerent
states alike. Until World War I (WWI), infectious diseases
rather than battle and non-battle injuries were the main
causes of morbidity and mortality among soldiers, as well as
in the affected civilian populations [1]. Among the 12 ‘war
pestilences’ delineated by Prinzing [2], ﬁve were vector-
borne: plague, yellow fever, malaria, louse-borne typhus, and
louse-borne relapsing fever. Since the Russo-Japanese War
(1904–1905) and WWI, partly because of developments in
weapons and advances in military hygiene and disease-control
measures (e.g. vaccination, chemoprophylaxis, antibiotic
treatment, personal protection, and control measures against
vectors), there has been a continuous decline in the inci-
dence of infectious diseases among soldiers as well as in civil-
ian populations [3]. During World War II (WWII), vector-
borne disease presented a permanent threat to the ﬁghting
ability of the belligerents [4]. By then, the impacts of many
infectious diseases as causes of mortality or morbidity within
the military had changed; they had gone from presenting
potentially lethal threats to being primarily curable illnesses.
However, infectious diseases remain of central importance in
developing countries in terms of morbidity or mortality, and
the historical impact of war in light of the current emergence
or re-emergence of vector-borne diseases worldwide is still
relevant today [5]. The military invasion of isolated ecological
niches, the disruption of human and zootic habitats, popula-
tion movement, the destruction of local infrastructures and
the promotion of local conditions favourable to the wildlife
reservoirs of disease all contribute to the risk of war directly
inﬂuencing disease emergence or re-emergence [6]. In fact,
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most conﬂicts involving Western armies have occurred over-
seas, often in tropical and subtropical regions, thus increasing
the risk of vector-borne disease for the soldiers and for the
displaced populations. In 2009, 35 000 French soldiers
(Fig. 5) and more than 300 000 US soldiers were engaged or
posted overseas (Fig. 6). Vectors and associated diseases
have geographically, qualitatively and quantitatively changed
throughout the centuries, and vector-borne diseases pose a
growing problem for deployed forces on duty abroad [7,8].
Western armies engaged worldwide are continually forced
to develop new vector-control strategies for military deploy-
ments. A selection of relevant vector-borne diseases is pre-
sented in Table 1, listed according to their past and present
impact on the health and military readiness of deployed
forces. The diseases that have lost their signiﬁcance in the
context of military operations, owing to progress in science
and/or preventive medicine, are detailed in Table 2. The cur-
rent threats to deployed troops, the corresponding personal
protection and control strategies and the impact of war and
conﬂict on public health in general and on the natural course
of vector-borne diseases are presented and discussed herein.
Vectors and Vector-Borne Diseases of
Military Importance
Mosquito-borne diseases
Malaria. Anopheline mosquitoes are vectors of the ﬁve
human pathogenic malarial parasites: Plasmodium falciparum,
Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, and
Plasmodium knowlesi. In addition to other ‘war-stopping’ dis-
eases, such as dengue and sandﬂy fevers, malaria has always
been a threat to soldiers on duty, from antiquity to modern
conﬂicts. In 1809, during the Walcheren Expedition, 10 000
of 15 000 British troops became ill, and 4000 may have died
from malaria [9]. In Macedonia (during WWI), the malaria-
weakened British, French and German armies were unable
to proceed for 3 years. Sixty thousand French soldiers were
diagnosed as having malaria, and 20 000 of them were with-
drawn to France [10]. During WWII, malaria emerged as
FIG. 4. Mosquito bites in a French soldier in Gabon, F Page`s.
FIG. 2. Cutaneous lesihmaniasis in a French soldier, courtesy of
JJ Morand.
FIG. 3. Malaria attack in a soldier in Ivory Coast, courtesy of
R Migliani.
FIG. 1. Aedes albopictus, courtesy of J Gathany.
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one of the main causes of illness among troops in tropical
areas. Subsequent to the fall of the Philippines in 1942, in the
ﬁnal stage of battle, the hospitalization rate reached 500–700
personnel per day in US forces, the equivalent of a battalion
a day lost to malaria alone [11]. In some Mediterranean
zones with a more equable climate, outbreaks of malaria
during the transmission season jeopardized several military
campaigns [12]. During the Italian campaign in 1944, 8000
British soldiers were struck down by malaria prior to the
battle of Monte Cassino. In the Sicilian campaign also, hospi-
tal admissions for malaria (21 482) outnumbered battle casu-
alties (17 375) [13].
In May 1943, General MacArthur observed that ‘This will
be a long war, if for every division I have ﬁghting the enemy,
I must count on a second division in the hospital with
malaria and a third division convalescing from this debilitating
disease’ [14].
Victory was possible because, taking into account the
experiences in the Spanish–American War in Panama and in
WWI, the US Army developed a new Preventive Medicine
Service in 1940 that included a Malaria Control Branch as
well as an Insect and Rodent Control Branch.
During the post-WWII conﬂicts (in Indochina, Malaysia,
and Korea), malaria’s impact on deployed forces was strongly
Post-colonial conflicts1948 to 1962French forces posted overseas
Past War, conflicts and peace keeping operations from 1990  to 2008
War and peace keeping operations in 2009
FIG. 5. Current repartition of French forces
posted overseas and engagements from World
War II to 2009.
Past War, conflicts and peace keeping operations from WWIIto 2008
US forces posted overseasWar and peace keeping operations in 2009
FIG. 6. Current repartition of US forces pos-
ted overseas and engagements from World
War II to 2009.
CMI Pages et al. Threat of vector-borne diseases 211
ª2010 The Authors
Journal Compilation ª2010 European Society of Clinical Microbiology and Infectious Diseases, CMI, 16, 209–224
reduced by the introduction of improved prophylactic drugs
and improved vector-control and personal protection mea-
sures (PPMs) [14,15]. However, during the Vietnam War,
the development of chloroquine resistance resulted in unsus-
tainable losses due to malaria, and threatened the success of
military operations [15,16]. Since this period, new antimalar-
ial drugs have been developed for chemoprophylaxis and
treatment, and vector-control regimens as well as protective
measures have been improved. In the last 30 years, however,
training or intervention of Western armies in malaria-ende-
mic areas has led to malaria outbreaks on many occasions
[17–23]. Poor compliance with routine prophylaxis (e.g. che-
moprophylaxis, repellent use, and proper use of impregnated
uniforms) and the impossibility of performing environmental
control (e.g. sanitation of potential mosquito breeding places
and habitats in combat areas, including the use of impreg-
nated bed-nets) resulted in malaria outbreaks in the US,
French, Italian, Australian, British and Dutch Forces [24–32].
During this period, resistance to most of the drugs used in
treatment of or chemoprophylaxis for both P. falciparum and
P. vivax increased or emerged [33]. Malaria currently is, and
will be, a major threat to the health of soldiers, as well as
their readiness for combat.
Mosquito-borne viruses. Many mosquito-borne viruses can
have a severe impact on soldiers’ health, on their readiness
for combat, and on the capability of forces during deploy-
ments. Among them, dengue and chikungunya fever viruses,
endemic in many parts of the world and still spreading geo-
graphically, are the most frequently encountered. With high
levels of morbidity, reaching devastating attack rates up to
83% during the 2001 epidemic in Southern America, dengue
fever (DF) can be responsible for the incapacitation of a
large number of troops. During WWII, nearly 90 000 cases
of DF were reported by the US Army [4]. Morbidity was
very high in some areas, e.g. Saipan, where nearly one-third
of the troops stationed there contracted the disease
between June 1944 and September 1944. During the
Vietnam War, although a few cases of DF and other mos-
quito-borne fevers, e.g. chikungunya fever, were reported
[34], the results of the studies on fever of unknown origin
(FUO) conducted during the evacuation of ﬁeld hospitals
indicated that almost 15% of these fevers were caused by
dengue or chikungunya viruses [35,36]. Regarding the high
rate of hospitalization for FUO (40–70 admissions/
1000 men/year from 1965 to 1970), the impact of these
diseases has obviously been underestimated. Since then, DF
TABLE 1. Past and present impact of vector-borne diseases of military importance among deployed troops
Past threats Present threats
Other diseases of less
importance
Sandﬂy-borne diseases Sandﬂy fever
Old World cutaneous leishmaniasis
New World mucocutaneous
leishmaniasis
Visceral leishmaniasis
Sandﬂy fever
Old World cutaneous leishmaniasis
New World mucocutaneous leishmaniasis
Visceral leishmaniasis
Oroya fever
Mosquito-borne diseases Malaria
Lymphatic ﬁlariasis
Yellow fever
Japanese B encephalitis
Dengue fever
Chikungunya disease
Malaria
Dengue fever
Chikungunya disease
Rift Valley fever virus
West Nile virus
O’nyong nyong virus,
Semliki Forest virus,
Sindbi virus, and other
mosquito-borne viruses
Flea-borne diseases Plague
Murine typhus
Plague?
Murine typhus?
Flea-borne spotted fever
Louse-borne diseases Typhus
Trench fever
Louse-borne relapsing fever
Tick-borne diseases Rocky mountain spotted fever
Mediterranean spotted fever
African tick bite fever
Other common tick-borne
spotted fevers
Ehrlichiosis
Q-fever*
Tularemia*
Crimean–Congo hemorrhagic fever
Tick-borne encephalitis
Rocky mountain spotted fever
Mediterranean spotted fever
African tick bite fever
Other common tick-borne
spotted fevers
Ehrlichiosis
Q-fever*
Tularemia*
Crimean–Congo hemorrhagic
fever
New pathogenic
rickettsiae (Rickettsia
slovaca, Rickettsia
helvetica, and Rickettsia
sibirica mongolitimonae)
‘Rickettsia of unknown
pathogenicity’
Colorado tick fever
Kemerovo tick fever
Other tick-borne fevers
(Dugbe or Banjha virus)
Omsk hemorrhagic fever
Kyasianur Forest disease
Alkhurma virus hemorrhagic fever
Human babesiosis
Mite-borne diseases Scrub typhus Scrub typhus Rickettsial pox
Tsetse ﬂy-borne diseases Sleeping sickness Sleeping sickness
Kissing bug-borne diseases Chagas disease Chagas disease
*: the main risk for forces is not the vector borne transmission.
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has been considered to be a potential cause of febrile illness
in troops deployed in tropical areas; it has been reported
among French forces in New Caledonia (1989), French Poly-
nesia, and the West Indies (1997), among US forces in
Somalia (1992–1993), and among Australian forces and Ital-
ian troops in East Timor (1999–2000) [37–41]. Chikungunya
fever has always been of concern for troops engaged in
known endemic areas in Asia, and sporadic cases have also
been recorded among French troops in Africa. A new vari-
ant of the chikungunya virus (CHIKV), formerly vectored
mainly by the yellow fever mosquito Aedes aegypti, has now
been repeatedly associated with a new vector, Aedes
albopictus (the ‘Asian tiger mosquito’), which, coincidentally,
has dispersed worldwide after introduction into the USA
and subsequent adaption to temperate regions. Conse-
quently, in Gabon and Cameroon, French forces have been
affected by CHIKV outbreaks in 2006 and 2007 [42–44].
Recently, A. albopictus-vectored new-variant CHIKV out-
breaks, characterized by a single adaptive gene mutation
providing a selective advantage for transmission by this mos-
quito, have occurred recently, resulting in massive outbreaks
in India, Reunion Island, and Mauritius [45,46]. During the
2005–2006 CHIKV outbreak in Reunion Island, 35% of
770 000 inhabitants were infected during a 6-month period.
French forces stationed on the island were also affected [47].
A military cohort of soldiers exposed to CHIKV during this
TABLE 2. Controlled vector-borne diseases
Past signiﬁcance Control measures
Epidemic typhus Historically, major epidemic typhus outbreaks occurred in many
wars, from the war of Granada (1482–1492) to WWI. During
and after WWI, a typhus epidemic raged between 1917 and
1923, in eastern Europe, but owing to the effectiveness of
louse-control measures (heating clothing to kill lice and eggs and
mandatory bathing for troops), there was no typhus on the
western front [126,186]
During WWII, because of advances made in diagnostics,
therapeutics, louse-control methods, DDT and vaccine
development (Cox’s chick embryo vaccine), there were only 104
cases recorded and no deaths in US Army, despite a massive
epidemic with up to 10% mortality rates in the civilian population
(Egypt, French North Africa, and Naples) [187,188]. Actually,
epidemic typhus is no longer a problem for troops [189].
Nevertheless, epidemic typhus can re-emerge as a result of a
catastrophic breakdown of social conditions [190–193]
Trench fever During WWI, trench fever caused one-third of all illness in the
British army and one-ﬁfth of all illness of the Allied forces [126].
Trench fever was controlled by the same effective control
measures use to control typhus [186]. During WWII, large-scale
epidemics occurred on the eastern front in Ukraine and
Yugoslavia [126]
Owing to the effectiveness of louse-control measures, trench fever
is actually not of concern for troops. Nevertheless, sporadic
trench fever cases are regularly described in many parts of the
world, and trench fever could re-emerge as a result of war
Louse-borne
relapsing fever
From 550 to WWI, louse-borne relapsing fever occurred in
massive epidemics in Europe, the Middle East and North Africa
[197194]. During WWI, a major outbreak got all Greek army
in the oriental front. Soldiers, natives of West Africa returning
from Middle East Theatre, introduced the disease into Guinea
and started an epidemic which literally decimated the population
of the Sudan belt of tropical Africa [197194]
During WWII, owing to scientiﬁc advances, only 151 cases
occurred in the US Army, despite the fact that an epidemic in
North Africa produced an estimated one million cases and some
50 000 deaths. During the Korean War, lice infestations were
frequent in South Korean soldiers and North Korean and
Chinese prisoners, but only 60 louse-borne relapsing fever cases,
with two deaths, were reported by US physicians
[198195]. Louse-borne relapsing fever is actually not of concern
for troops
Yellow fever Yellow fever has been a substantial cause of mortality for the
forces involved in South America, the West Indies and Africa,
and was considered to be the main factor in defeat. During the
Haitian–French War (1801–1803), Napoleon’s largest
expeditionary force (50 000 soldiers) was thoroughly destroyed
by yellow fever [9]
Since the introduction of the yellow fever vaccine, this disease has
ceased to be a problem. With the systematic immunization of
troops before deployment in endemic areas, yellow fever is not a
threat for forces
Tick-borne
encephalitis
This risk was underscored by serological studies conducted among
soldiers or infection studies conducted on ticks collected in the
ﬁeld [80,88,196]
An effective inactivated whole virus vaccine against tick-borne
encephalitis is available and is used by most European armies
living or deployed in endemic areas. In Bosnia, an accelerated
schedule for tick-borne encephalitis vaccination was implemented
in deployed US troops [197]
Japanese
encephalitis
During the Indochina War and Vietnam War, a few cases of
Japanese B encephalitis were recorded; the cases presented a high
degree of lethality, but had no effect on French or US forces’
ﬁghting strength [14,34]
Currently, with the new highly effective and well-tolerated
Japanese encephalitis vaccine, this disease should no longer be a
problem for forces deployed in endemic areas
Q-fever Q-fever is a zoonotic disease distributed worldwide and caused by
Coxiella burnetti. C. burnetti, found in more than 40 tick species, is
usually transmitted in humans by inhalation of infectious aerosol
[83]. Such outbreaks have already been described in forces on
duty [198–202]
Q-fever is of great military concern, but it cannot be considered
to be a vector-borne disease threat
Tularemia Tularemia, a zoonotic disease caused by the highly infective,
virulent, non-sporulating Gram-negative coccobacillus Francisella
tularensis, is found throughout most of the northern hemisphere
in a wide range of animal reservoir hosts. It is transmitted to
humans by various modes, including direct handling of infectious
carcasses, ingestion of contaminated food or water, arthropod
bites, including tick bites, or inhalation of infectious dusts or
aerosols [203]
The last epidemic manifestations in deployment areas were all
waterborne or rodent-borne, and no case has been reported
among Western military forces [84]. Tick-borne tularemia is not
of military concern, but the use of tularemia as a biological weapon
remains a concern [85]
WWI, World War I.
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outbreak has been screened for infection. Preliminary results
are worrying; the attack rate was as high as that within the
general local population, and previously unknown persistent
manifestations, e.g. incapacitating chronic peripheral rheuma-
tism or chronic fatigue, are not infrequent [48]. In addition,
cardiac forms have been described for the ﬁrst time [49]. Out-
side the known range of endemicity, which is limited to Asia
and Africa, the ﬁrst CHIKV epidemic occurred in Italy in 2007,
thus proving its potential to become endemic in southern
Europe, where the temperate variant of the Asian tiger mos-
quito was introduced in 1990 [50]. In addition to its public
health importance, CHIKV is not only a threat to combat
readiness, but also poses a major threat to soldiers’ health.
Additionally, many other mosquito-borne viruses are of
special concern for the safety of soldiers, and sporadic cases
are regularly recorded (e.g. West Nile virus, Rift Valley fever
virus, O’nyong nyong virus, Semliki Forest virus, and Sindbi
virus) [51–53]. Mosquito-borne viruses, because of their
impact on health in general and/or their high morbidity lev-
els, always pose a threat to military forces deployed to dis-
ease-endemic areas.
Lymphatic ﬁlariasis. Lymphatic ﬁlariasis is caused by infection
with the ﬁlarial nematodes Wuchereria bancrofti, Brugia malayi,
and Brugia timori, and––depending on the major local vectors
and transmission chains––is transmitted by mosquitoes of dif-
ferent genera (Anopheles sp., Culex sp., Aedes sp., and Manso-
nia sp.). Clinical manifestations vary according to the
nematode species, as well as the age, level of infection and
immune status of the patient [54]. First acute attacks could
occur even after a short exposure [54]. During WWII,
numerous outbreaks were reported, with a high rate of
morbidity (one-third of the exposed population up to 70%),
which had an immediate impact on troop strength [55]. Dur-
ing the Indochina War, one outbreak in returnees was
reported [56]. Only serological evidence was found during
the Vietnam War and in Australian soldiers deployed for a
6-month duty in Timor-Leste [57,58]. Nevertheless, occiden-
tal forces deployed to endemic areas may encounter severe
outbreaks, as historically documented during WWII, or spo-
radic cases; and physicians should not exclude acute manifes-
tations during combat and in returnees.
Sandﬂy-borne diseases
Phlebotomine sandﬂies inhabit diverse biotopes, ranging from
desert areas of the Middle East to tropical rainforests of
South America.
Most adult sandﬂies are crepuscular and nocturnal in their
biting activity. They can transmit several sandﬂy fever group
phleboviruses, Leishmania spp., and Bartonella spp.
Sandﬂy fever. The different species responsible for transmis-
sion of sandﬂy fever viruses have a focal, but wide, geograph-
ical distribution [59]. Foci are reported from southern
Europe, the Middle East and Central Asia, where these spe-
cies are endemic. In case groups of non-immune soldiers
who have been engaged in endemic areas, high infection
rates may occur. Owing to the short incubation period and
attack rates ranging from 10% to over 50%, the impact of
this virus on the ﬁghting ability of military forces can be
highly signiﬁcant [60]. Thus, sandﬂy fever has long been a dis-
ease of considerable medical importance to military forces
(e.g. to the British troops in India, Pakistan, and Palestine,
and to Austrian soldiers in Yugoslavia in the nineteenth cen-
tury). During WWII, sandﬂy fever was a major problem for
forces in the Mediterranean basin, and 19 000 cases were
reported among Allied forces [61]. Since then, only limited
outbreaks have been reported, among Soviet troops in
Afghanistan, as well as in Swedish United Nations troops and
Greek troops in Cyprus [62–64]. Sandﬂy fever was consid-
ered to be a major threat during the acclimatization process
in endemic areas prior to movement into the Gulf War
zones. Curiously, with a single small outbreak, sandﬂy fever
has not yet been reported as a problem in Iraq or Afghani-
stan, even though leishmaniasis, another sandﬂy-borne dis-
ease, is frequent and of great concern [65,66]. Despite the
low frequency of occurrence, a recent seroepidemiological
study in the native Afghan population, performed in the Kon-
doz area, revealed a seroprevalence rate of 9.2% against
Naples sandﬂy fever virus, thus indicating that sandﬂy fever
poses a continuous threat (Dobler et al., IMED Congress,
2007, abstract 16.025).
Leishmaniasis. Leishmaniasis, a parasitic disease caused by
infection due to protozoa of the genus Leishmania, is ende-
mic in many tropical, subtropical and temperate regions of
the world, frequently involving the areas of activity of Wes-
tern armies. Cutaneous leishmaniasis (CL), mucocutaneous
leishmaniasis and visceral leishmaniasis (VL) have the poten-
tial to cause explosive outbreaks in non-immune communi-
ties exposeto the parasite within endemic areas. From 1942
to 1945, among the 1000 cases of CL recorded by the US
Army in all theatres, 630 cases occurred within 3 months in
a single outbreak in the Karun River Valley of Iraq [60]. Old
World CL is endemic in many parts of the Middle East, as
well as in Central and Southeast Asia, where it is caused by
two species of Leishmania: Leishmania major, the causative
agent of rural zoonotic CL, and Leishmania tropica, the causa-
tive agent of urban anthroponotic leishmaniasis. In this part
of the world, Israeli, Russian and Fijian soldiers have experi-
enced severe episodes of CL [67] (Modi et al., 39th Annual
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Meeting of the American Society of Tropical Medicine and
Hygiene, 1990, abstract 387).
During the ﬁrst Gulf War, among the 40 cases of leish-
maniasis in US soldiers recorded from Iraq, 12 were VL due
to an unexpected high frequency of L. tropica visceralization
[68].
Viscerotropism had not been previously associated with
this species [70]. From 2001 to 2006, the US armed forces
experienced only four cases of VL (two from Afghanistan
and two from Iraq) but, in the same period, 1283 cases of
CL (of which at least 90% occurred after a tour of duty in
Iraq) were recorded after an initial outbreak in 2003 near
the Iranian border [69]. Estimates of up to 2500 cases of CL
among US soldiers have been cited, i.e. an attack rate of 1%
among US troops serving in Iraq during the period 2003–
2004 [70]. Dutch, German and British forces engaged in the
International Security Assistance Force in Afghanistan have
also experienced zoonotic CL outbreaks exceeding 200
cases, but have rarely been affected by the outbreaks of an-
throponotic leishmaniasis continuously occurring in urban
areas of larger towns of the country and in refugee camps
[71–73]. Also, 126 cases of VL were reported by US armed
forces during WWII, mostly in the Indian, Chinese and Medi-
terranean theatres [4]. The last cases of VL reported by
French forces occurred in Algeria at the end of the colonial
period [74]. Unlike the experience of the Gulf Wars, Old
World leishmaniasis has been encountered mostly by Wes-
tern forces, and cases or outbreaks of New World mucocu-
taneous leishmaniasis have been regularly reported by
European and US armed forces in training or in operations
in Central and South America [68,75–78] (Grogi et al.,
Annual Meeting of the American Society of Tropical Medi-
cine and Hygiene, 1993, abstract 169).
Ticks and tick-borne diseases
Hard and soft ticks are ectoparasites that feed on every class
of vertebrate blood host and occur almost worldwide [81].
They can transmit bacterial, viral and parasitic diseases. Sol-
diers on duty overseas or in training camps in their own
country frequently enter multiple tick-infested ecological
niches, and are therefore highly exposed to soft and hard
tick bites. There is always a possibility of outbreaks of tick-
borne disease among troops, sometimes threatening the
health or the life of soldiers, and simultaneously threatening
their mission. Serological studies of armed forces, and tick
analyses conducted in training camps or overseas deploy-
ments, have underscored these risks. In 1997, 2–15% of the
ticks removed from soldiers in US military camps in the USA
were infected with Ehrlichia sp., and 11–21% were infected
with Borrelia burgdorferi sensu lato [79]. Among a total of
6071 Ixodes ricinus ticks collected on Swiss Army training
grounds in ﬁve regions of Switzerland, 26.54% harboured
B. burgdorferi sensu lato, 1.18% harboured members of the
Ehrlichia phagocytophila genogroup, and 0.32% harboured the
European tick-borne encephalitis virus [80]. Antibodies
against B. burgdorferi were investigated in Finnish Army
recruits training during summer in an endemic region, and
IgM antibody levels increased in 11.9% of study recruits [81].
In the summer of 2001, Astrakhan fever Rickettsia was
detected in ticks collected in Kosovo from an asymptomatic
French soldier of the United Nations troops [82]. Human
babesiosis is not currently of military concern. However, Q-
fever and tularemia are of great military concern. Q-fever is
mainly transmitted in humans by inhalation of infectious
aerosols, and tick-borne transmission is not considered to
be important [83]. In the same way, the agents of tularemia
in military duty areas such as Kosovo are mainly waterborne
or rodent-borne, and are rarely mosquito-borne or hard
tick-borne. Another problem is the potential use of Francisel-
la tularensis as a biological weapon [84,85].
Lyme disease. Lyme disease, caused by members of the
B. burgdorferi sensu lato complex, is mainly transmitted by
hard ticks of the genus Ixodes [86,87]. This disease is recog-
nized in many parts of the world, including large areas of
North America, Europe, Asia, Australia, and focally in North
Africa. Western armies on duty or in training are regularly
confronted with Lyme disease. Serological studies, conducted
among soldiers of different armies, have brought attention to
the exposure of soldiers to B. burgdorferi [88,89]. At present,
only sporadic cases have been recorded in armed forces,
essentially in US forces in Europe, exceeding the case num-
bers recorded in training areas in the continental USA
[81,90]. Lyme disease is of military concern because of its
debilitating and potentially long-term effects on soldiers’
health [91]. Doxcycline, employed as a chemoprophylactic
regimen, has been proposed in high-endemicity areas to
compensate for the shortcomings in PPMs against ticks, but
its efﬁcacy is not yet clear.
Tick-borne relapsing fevers. Soft tick-borne Borrelia spp. of the
relapsing fever group are transmitted by argasid ticks of the
genus Ornithodorus, and are responsible for tick-borne relaps-
ing fevers in many parts of the world: America, Africa, Asia,
and Europe [92]. Tick-borne relapsing fevers are of military
concern for two reasons: the possible occurrence of out-
breaks and the resulting impact on combat strength; and the
potentially lethal pathogenicity associated with some Borrelia
species, e.g. Borrelia persica. Western armies could currently
be confronted with tick-borne relapsing fever while on duty
CMI Pages et al. Threat of vector-borne diseases 215
ª2010 The Authors
Journal Compilation ª2010 European Society of Clinical Microbiology and Infectious Diseases, CMI, 16, 209–224
in known endemic areas in the Middle East (Lebanon and
Cyprus) and Central Asia (Afghanistan), or during training in
Africa [92,93].
Tick-borne spotted fevers. More than a dozen types of tick-
borne spotted fevers, caused by different species of Rickett-
sia, have been described throughout the world, ranging from
benign to potentially fatal disease [94]. Rocky Mountain spot-
ted fever, caused by Rickettsia rickettsii, is one of the most
severe fevers and is endemic in North, Central and South
America.
Rocky Mountain spotted fever, transmitted by Dermacentor
spp. or Amblyomma spp. ticks, is a rickettsial disease with
important consequences for the US military, given its preva-
lence in areas where military training takes place and its
lethality (up to 30% in the pre-antibiotic era and 4% nowa-
days) [94]. During the spring of 1989, members of a military
unit originating from a non-endemic area (Maryland, USA)
participated in a 2-week-long training manoeuvre in the
states of Arkansas and Virginia. A seroepidemiological inves-
tigation among unit members revealed that 15% and 2% of
the soldiers had been infected by R. rickettsii and Ehrlichia
canis, respectively [95]. Other potentially life-threatening
tick-borne rickettsial diseases include Mediterranean spotted
fever, transmitted by the brown dog tick, Rhipicephalus san-
guineus, in southern Europe, northern Africa, and, less fre-
quently, sub-Saharan Africa [96]. Severe forms have been
reported in 6% of cases, with mortality rates as high as 2.5%.
However, African tick bite fever (ATBF), caused by Rickettsia
africae and transmitted by Amblyomma spp. bites, probably
represents the main tick-borne rickettsiosis threatening sol-
diers in the ﬁeld in sub-Saharan Africa. Amblyomma ticks are
usually highly infected and actively attack people or animals
that enter their biotope. Thus, cases of ATBF often occur in
clusters among subjects entering the bush, e.g. tourists or
soldiers [97,98]. US troops have already been involved in
such outbreaks; among the 169 US Army soldiers deployed
to a remote area of Botswana for 2 weeks in January 1992
for a ﬁeld training exercise, more than 30% developed a feb-
rile illness within 5 days of their return. This high attack rate,
experienced after such a short exposure period, emphasizes
the high infection pressure of R. africae in endemic areas
[99]. Although severe clinical forms have been described, it
is usually associated with mild disease only. ATBF infection
and clinical manifestations have also been observed in tour-
ists who used daily doses of 100 mg of doxycycline for
malaria chemoprophylaxis, but no data concerning compli-
ance with chemoprophylaxis were made available [97]. Many
other rickettsiae, including emerging pathogens such as Rick-
ettsia slovaca and Rickettsia helvetica, have been recently
reported in Europe, and may be of concern for military
forces [94]. Moreover, rickettsiae of unknown pathogenicity,
e.g. Rickettsia raoultii, vectored by Dermacentor reticulatus,
have already been found in ticks removed from soldiers
[100]. The aetiology of the most important outbreak (more
than 1000 cases recorded at Camp Bullis in Texas during
WWII), assumed to have been, probably, tick-borne Bullis
fever, is still unknown [101–104]. Tick-borne rickettsial dis-
eases are always considered to be of special concern for
armed forces.
Tick-borne ehrlichioses and anaplasmoses. Ehrlichia chaffeensis,
Ehrlichia ewingii and Anaplasma phagocytophilum are emerging
tick-borne pathogens [105]. The diseases usually present as
ﬂu-like illnesses, but cases range from asymptomatic infection
(Europe) to severe illness, sometimes with fatal outcomes
(North America). Ehrlichial diseases have been described in
North America and in Europe, but cases have also been
recorded in Asia, and infected ticks have been identiﬁed in
Africa. Outbreaks have already occurred in military forces,
and serological studies have demonstrated that they have
been exposed to these pathogens. An outbreak of ehrlichio-
sis that occurred in members of an army reserve unit after
ﬁeld training in an area of New Jersey has been described by
Petersen et al. [106]. A prospective, seroepidemiological
study of spotted fever group rickettsiae and Ehrlichia infec-
tions was performed among 1194 US military personnel
exposed in a heavily tick-infested area of Arkansas in 1990.
Seroconversions to spotted fever group rickettsiae occurred
in 30 persons (2.5%), whereas seroconversion to Ehrlichia
species occurred in 15 (1.3%) [107]. Chemoprophylaxis with
daily doses of 100 mg of doxycycline for Ehrlichia infections
has successfully prevented infection and clinical manifesta-
tions in dogs, but no data are available for the use of doxy-
cycline in human chemoprophylaxis [108].
Tick-borne viruses. Approximately 100 viruses have been iso-
lated from ticks, among which only 20 are considered to be
pathogenic for humans. Tick-borne viruses are responsible
for three main syndromes, classiﬁed according to their clini-
cal manifestations: tick fever, tick haemorrhagic fever [2],
and tick encephalitis. As tick-borne encephalitis, both Central
Europe encephalitis and Russian spring–summer encephalitis,
is now easily preventable by vaccination, this disease is no
longer a problem. Viral tick fevers usually occur as a mild
disease, characterized by a biphasic fever with frontal head-
ache, myalgia, nausea, vomiting, and sometimes a rash. The
most famous types are the Colorado tick fever transmitted
by Dermacentor andersoni in the USA, and the Kemerovo tick
fever transmitted by Ixodes persulcatus in Siberia. Other tick-
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borne viral fevers have been described both in tropical and
in temperate areas, and could affect tick-exposed soldiers
(e.g. Dugbe virus fever in Central Africa, or Banjha virus
fever in the former Yugoslavia) [109].
Three main tick-borne viruses, all classiﬁed at biosafety
level 4, may cause severe haemorrhagic disease: Crimean–
Congo haemorrhagic fever (CCHF) virus, Omsk haemor-
rhagic fever (OHF) virus, and Kyasanur Forest disease (KFD)
virus. CCHF was ﬁrst noted in 1944–1945 among Soviet mil-
itary personnel assisting civilians in the war-ravaged Crimea.
Since then, CCHF has been considered to be an important
vector-borne disease of humans in southern Europe, Asia,
Africa, and the Middle East. Most of the outbreaks reported
since this ﬁrst description were linked to environmental
changes due to war or to new agricultural practices [110].
However, the most recent outbreaks were clearly associated
with contact with contaminated meat or infected sheep and
goats subsequent to an initial Hyalomma tick bite [111]. Nos-
ocomial and household transmission of CCHF has been com-
monly reported, and this must be taken into account for
military personnel as well as healthcare workers [112].
Recently, Western forces engaged in Kosovo were con-
fronted with an outbreak within the local population that
resulted in additional countermeasures by military units to
prevent transmission. Additionally, ﬁeld hospitals prepared
for potential outbreaks among soldiers [113,114]. In 2008, a
CCHF epidemic involving at least 23 cases occurred among
the Afghan population near Herat, Afghanistan [115]. In Sep-
tember 2009, a US soldier contracted the disease while sta-
tioned near Kabul, Afghanistan, subsequent to reporting a
tick bite, and died at Landtuhl hospital, Germany, days later
[116]. In the Middle East, besides CCHF, the Alkhurma virus,
a recently discovered tick-borne ﬂavivirus (biosafety level 4)
responsible for several cases of severe haemorrhagic fever in
Saudi Arabia, may be of special concern for deployed Wes-
tern forces [60,117]. OHF occurs primarily in western Sibe-
ria and KFD is limited to northern India. KFD and OHF,
both occurring in sylvatic enzootic foci, were always acquired
by people who had gone into forests.
Flea-borne diseases. Fleas exist worldwide, from sea level to
high altitudes [118]. They can affect human health in several
ways: as biting pests, burrowing ‘jiggers’, parasite intermedi-
ate hosts, and vectors of pathogens, e.g. bubonic plague
[119] and murine typhus [120].
Plague has affected military campaigns from antiquity to
WWII. Outbreaks occurred in several Mediterranean towns
and ports during 1943 and 1944. Thousands of cases
occurred in the local civil population during the Vietnam
War; however, beause of sanitation measures, systematic
chemoprophylaxis of contacts, and immunization, only a few
cases in military populations were recorded [121,122]. Since
WWII, plague has not affected military campaigns, but mili-
tary campaigns may contribute to the spread of plague,
owing to displacement of rats and their ﬂeas. An epidemic of
1005 cases in and around Dakar, Senegal, in 1943–1945, was
initiated by WWII ship transport activities, and small out-
breaks also occurred in France and Italy in 1945 [121]. Dur-
ing the Vietnam War, there were only ﬁve cases recorded in
vaccinated US troops, whereas thousands of cases occurred
in the local population. Subsequently, the disease expanded
into unaffected areas of the country [122]. Of the ﬁve US
military cases, one occurred in a returnee, who did not
transmit the disease to others [123]. Of great concern dur-
ing the later stages of the conﬂict was the prevention of pla-
gue importation into the USA via retrograde cargo. Enzootic
plague is primarily an infection of rodents in natural foci.
International forces can always be exposed to well-known
natural foci, e.g. the French forces or the United Nation
Organization forces in the east of the Republic of Demo-
cratic Congo [124,125].
Murine or endemic typhus. Endemic typhus, caused by Rickett-
sia typhi, is a natural infection in rats and rodents and is
transmitted among rats by the rat ﬂea [120]. Occasionally,
ﬂeas can transmit this infection to humans. During WWII,
there were 786 cases in the US Army, leading to 15 deaths,
with the majority of cases being recorded in the continental
USA [126]. During the Indochina War, 90 cases were
recorded among French soldiers in the Saigon arsenal [14].
In the Vietnam War, only a few cases were reported but, on
the basis of serological investigations, the Armed Forces Epi-
demiological Board determined that 15% of FUOs acquired
during the Vietnam conﬂict could be attributed to murine
typhus [35,36,127]. During the ﬁrst Gulf War, murine typhus
was considered to be a threat before deployment into the
endemic area of Kuwait [60]. The incidence of murine typhus
in armed forces is probably underestimated.
Mite-borne diseases
Scrub typhus.. Scrub typhus, caused by Orientia tsutsugamushi,
is transmitted to humans by the bite of numerous species of
larval trombiculid mites (Leptotrombidium spp.), popularly
known as ‘chiggers’. It is an acute febrile rural zoonosis that
is endemic in the Asian Paciﬁc region from Korea to Austra-
lia, and from Japan to India and Afghanistan [94]. During
WWII, with the deployment of Allied and Japanese forces
into endemic areas, scrub typhus attack rates were very high,
sometimes causing more casualties than those related to bat-
tles (18 000 cases and 20 000 cases, respectively, occurred
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among Allied forces and Japanese forces). The lethality rates
at that time ranged from 1% to 60% [126].
Outbreaks occurred when troops were in ﬁeld conditions
associated with bivouacs or the establishment of camps. At
the end of the war, mite-control regimens consisting of
impregnation of clothing with repellents (initially dimethyl
phthalate, later benzyl benzoate) and the preparation of
camp sites (oiling, cutting and burning of the vegetation over
an area of 100 yards around buildings or tents) signiﬁcantly
reduced the incidence rates. During the Indochina War,
6536 cases of scrub typhus and 158 deaths were recorded
in French forces but this incidence was probably underesti-
mated [15].
After the implementation of the generalized use of chl-
oramphenicol in 1951, no more deaths due to scrub typhus
among French forces were recorded. Although scrub typhus
caused no known deaths among American troops during the
Vietnam conﬂict, studies on the aetiology of FUOs con-
ducted throughout the war indicated that 20–30% of such
FUOs were due to scrub typhus [35,36]. These results and
the reports of outbreaks at the beginning of the conﬂict sug-
gest that scrub typhus was seriously under-reported and had
a mission-compromising inﬂuence in Vietnam [128]. US
forces have successfully conducted studies on the use of chl-
oramphenicol or doxycycline for scrub typhus prophylaxis
[129,130]. Regimens based on daily doses of 100 mg of
doxycycline for malaria chemoprophylaxis have failed to pre-
vent infection and clinical manifestations [131]. Presently,
scrub typhus chemoprophylaxis is not recommended,
because of the increase in the number of resistant O. tsutsu-
gamishi strains [132]. Now, sporadic cases or outbreaks are
regularly reported among forces on duty or in training in
endemic areas [133]. Both early and recent attempts to
develop a vaccine have been unsuccessful [134]. Scrub typhus
is an enduring threat to the battle-readiness of troops in
endemic areas and, because of some strains’ low susceptibil-
ity to antibiotics, a threat to soldiers’ lives. As at the end of
WWII, PPMs and campsite sanitation measures will continue
to be the rampart against mite bites.
Tsetse ﬂies and human African trypanosomiasis
The Glossinidae, or tsetse ﬂies, are found only in sub-Saha-
ran Africa. Glossina spp. are vectors of sleeping sickness, or
human African trypanosomiasis. Human trypanosomiasis is
endemic in West and Central Africa (Trypanosoma brucei
gambiense), where it manifests as a chronic disease leading to
death after some years; in East Africa, however, T. brucei rho-
desiense causes an acute disease leading to death in a few
months [135]. No direct impact on war has been reported
concerning this human trypanosomiasis, but the impact of
colonial conquest, of WWI and of the African civil war on
the extension of sleeping sickness is well documented [136–
138]. Nevertheless, Western forces deployed in endemic
areas, e.g. the European forces in the Democratic Republic
of Congo in 2003 and 2006, could be affected by the spread
of this life-threatening disease.
Kissing bugs
Among the 118 existing species of kissing bugs, or Triatomi-
nae, half have been shown, naturally or experimentally, to be
susceptible to infection with Trypanosoma cruzi, the causative
agent of Chagas disease [139]. Chagas disease can be trans-
mitted by the faeces of domestic or sylvatic members of the
Triatominae during a blood meal or by ingestion of food
contaminated with kissing bug faeces. Chagas disease has not
yet had a signiﬁcant impact on military operations; only spo-
radic cases have been recorded in US forces deployed in
Central America, and one acute case has been reported in
French forces stationed in French Guiana [137] (F. Page`s,
personal communication). In the Amazon, foodborne Chagas
outbreaks are not infrequent; and severe and acute manifes-
tations are more frequent in cases resulting from oral con-
tamination [140]. Western forces involved in training
exercises in the Amazon jungle must protect their food from
insects and wild fauna, must avoid cooking under lights that
attract kissing bugs, and must sleep under insecticide-impreg-
nated nets. Military physicians must be informed of this risk
to prevent its occurrence in the ﬁeld and to take it into
account in the medical follow-up of returnees.
Vector Control in Armed Forces
The burden of vector-borne diseases on armed forces could
be very signiﬁcant, and all Western armies have developed
vector-control strategies [141–143]. Medical intelligence
allows for the assessment of risks before deployment and
for the planning of preventive countermeasures. In the past
few years, military operations in rural or urban areas have
permitted the creation of entomological and epidemiological
risk models and maps of military settlements or theatres
using remotely sensed data [144,145].
Preventive countermeasures include PPMs and unit pro-
tection measures (UPMs). PPMs consist of proper use of uni-
forms, the application of repellent to exposed skin, the
application of permethrin to battledress uniforms, and the
use of insecticide-impregnated bed-nets, curtains, tents, and
window screens. UPMs include base camp selection, environ-
mental management, larviciding, space spraying, aerial spray-
ing, and indoor residual spraying. In a combat environment,
218 Clinical Microbiology and Infection, Volume 16 Number 3, March 2010 CMI
ª2010 The Authors
Journal Compilation ª2010 European Society of Clinical Microbiology and Infectious Diseases, CMI, 16, 209–224
PPMs are often the last line of protection for soldiers. For
UPMs to be effective, there must be good knowledge of the
entomological situation and the availability of certiﬁed per-
sons to implement the chosen vector-control methods. Many
of the tools currently used around the world in vector con-
trol and in personal protection derive from military research.
Most modern dusting devices and repellents were developed
by US forces. During WWII, aerosol bombs were perfected,
research in repellents was conducted, and three repellents,
dimethyl phthalate, Rutgers 612 (2-ethylhexane-1,3-diole),
and indalone, were recommended to the US Army; more-
over, DDT was developed, and the army, navy and air force
developed and deployed aerosol spray systems [146]. Per-
methrin-impregnated battledress uniforms have proved their
efﬁcacy against arthropod bites in many studies of the ﬁeld
[147–151]. Since their ﬁrst use in 2001, factory-based
impregnated battledress uniforms have been developed by
German and French forces for the protection of their sol-
diers. Synergistically combined with DEET skin repellent use,
this PPM proved highly efﬁcious during recent deployments
[152,153]. Most of these recently developed measures are
now currently used to effectively protect refugees and dis-
placed populations who are threatened by vector-borne,
especially louse-borne, diseases. Other protective measures,
which include impregnated tents, curtains, and plastic sheet-
ing, are, or will be, adapted for wider military use [154,155].
Entomological Studies in Armed Forces
To design an effective vector-control strategy, it is necessary
to be highly knowledgeable about the entomological situation
within deployment areas. Entomological studies are common
tools in the assessment of health hazards before and during
deployment for most Western armies [28,42,65,75,156,157].
For example, concerning malaria transmission, such studies
provide information on the risk level according to the loca-
tion of troops and on the insecticide susceptibility of vectors
in the ﬁeld. A recent study in the Coˆte d’Ivoire showed that
the risk of malaria for soldiers in rural areas was very high
(without protection, the number of infected bites for a sol-
dier ranged from 30 to more than 300 during a 4-month
tour of duty) and indirectly demonstrated the efﬁciency of
the malaria-control schedule of the French forces [158]. Mili-
tary research strategies are not only of special interest for
the military community; study data may result in the transfer
of important public health information concerning the epide-
miology of vector-borne disease and trends for the local
population, e.g. the ﬁrst report of malaria transmission in
downtown Dakar, the ﬁrst identiﬁcation of the Kdr mutation
in Anopheles gambiae molecular form M, and the epidemiol-
ogy of leishmaniasis and malaria in Afghanistan [159–162].
War, Vector-Borne Disease, and Civilian
Populations
As vector-borne diseases have an impact on war, wars also
have an impact on the development of vector-borne disease
[163]. Infected or infested soldiers, returnees, migrants and
refugees act as reservoirs and carriers of pathogens in areas
where they were previously not present [164]. If competent
vector populations exist in these areas, large-scale epidemics
can occur in non-immune local populations, and vector-
borne disease could become endemic. In the last century,
WWI-related movements in Central Africa initiated the dev-
astating spread of sleeping sickness in the 1920s, civil war in
the Sudan led to visceral leishmaniasis and sleeping sickness
outbreaks, the installation of Afghan refugees in Pakistan was
followed by an increase in the global burden of malaria, and
the inﬂux of Somali refugees into Oman led to a malaria out-
break in a formerly malaria-free region [165–171]. At the
same time, refugees and displaced people are often more
vulnerable to vector-borne disease because of their poverty,
their lack of immunity to the endemic diseases of their new
location, the difﬁculty in gaining access to drugs, their poor
nutritional status, their living conditions, and, sometimes,
their installation into natural foci of zoonotic disease [172–
174]. They are exposed to many arthropod-borne diseases,
such as malaria, typhus, murine typhus, louse-borne typhus,
plague, leishmaniasis, lymphatic ﬁlariasis, and sleeping sickness
[122,175–180]. The destruction of vital infrastructure, includ-
ing the health system, is another factor in the emergence or
extension of vector-borne disease in a given region [181–
183]. The return of refugees to their own land is another
factor in the spread of vector-borne disease. For example, in
Cameroon in 1916, refugees returning from Equatorial Gui-
nea came back with sleeping sickness, and in Afghanistan,
malaria is now present in new areas [138,159]. Clearly, the
toll of wars should include both human lives lost in direct
conﬂict and indirect deaths due to the loss of services and/
or insufﬁcient infrastructure [184,185].
Conclusions
Vector-borne disease and war are long-standing companions.
Owing to commercially available immunization programmes,
some diseases no longer pose a danger to military personnel
and military operations (e.g. yellow fever and Japanese enceph-
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alitis), but others, old re-emerging diseases and newly emerging
diseases, are still of concern in the absence of speciﬁc and efﬁ-
cient prophylaxis. Scientiﬁc progress has brought about a
reduction in the impact of arthropod-borne diseases on mili-
tary forces, but the threat is always present, and shortcomings
in vector control or in the application of PPMs could cause
these diseases to have the same impact as they did in the past.
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